GLP1-RA Use and Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes.

Lee JJ, Brothers T, Kim LA, Ward KE, Yusuf H, Wen X.

Open source

DOI
10.1016/j.oret.2026.08.029
Published
2026-09-03
Container
Ophthalmol Retina
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.oret.2026.08.029,
  title = {GLP1-RA Use and Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes.},
  author = {Lee JJ and  Brothers T and  Kim LA and  Ward KE and  Yusuf H and  Wen X.},
  year = {2026},
  journal = {Ophthalmol Retina},
  doi = {10.1016/j.oret.2026.08.029},
  url = {https://doi.org/10.1016/j.oret.2026.08.029}
}

RIS

TY  - JOUR
TI  - GLP1-RA Use and Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes.
AU  - Lee JJ
AU  -  Brothers T
AU  -  Kim LA
AU  -  Ward KE
AU  -  Yusuf H
AU  -  Wen X.
PY  - 2026
JO  - Ophthalmol Retina
DO  - 10.1016/j.oret.2026.08.029
UR  - https://doi.org/10.1016/j.oret.2026.08.029
ER  - 

APA

JJ, L., T, B., LA, K., KE, W., H, Y., & X., W. (2026). GLP1-RA Use and Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes.. Ophthalmol Retina. https://doi.org/10.1016/j.oret.2026.08.029

Source records